PATENT CLAIM ANALYSIS

Application Number: 16204085
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "683000"]

Abstract:
The present invention relates to substituted stilbenes and dienones which exhibit unexpected dual activity, as inhibitors of NFκB and as agonists (activators) of Nrf2. In particular, these compounds show dual activity and makes them particularly useful in the treatment of inflammation, including chronic inflammation and a number of related chronic disease states and conditions, including neurological diseases, including Alzheimer's, Alzheimer's prodrome and mild cognitive impairment, and other diseases and conditions, such as Parkinson's disease, depression, bipolar disorders and autism spectrum disorders. Compounds, pharmaceutical compositions and methods of treatment are described.

Claim (Index 30):
A compound according to the chemical structure: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.60294
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14249150', '15036968', '16124391', '15475704', '14777917']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7770803363779044
- 35 USC 102 Novelty (BERT): 0.5144550149857874
- Combined Prediction Score: 0.7508178042386927
- Mean Citation Score: 284.544956
- Max Citation Score: 292.06076
- Similarity Product: 209.4256716532135

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test